title: Given the complexity of the human genome, can 'personalised medicine' or 'individualised drug therapy' ever be achieved?
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Nebert
mesh_terms: D004358:Drug Therapy; D015894:Genome, Human; D016045:Human Genome Project; D006801:Humans; D007206:Individuality; D040641:Quantitative Trait Loci
references.citation: Trends Pharmacol Sci. 2006 Nov;27(11):580-6
references.pmid: 17005258
references.citation: Eur J Pharmacol. 2004 Oct 1;500(1-3):267-80
references.pmid: 15464039
references.citation: N Engl J Med. 2009 Apr 23;360(17):1699-701
references.pmid: 19369661
references.citation: Am J Pharmacogenomics. 2003;3(6):361-70
references.pmid: 14672516
references.citation: Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):34-42
references.pmid: 15982695
references.citation: N Engl J Med. 2009 Apr 23;360(17):1696-8
references.pmid: 19369660
references.citation: N Engl J Med. 2009 Apr 23;360(17):1759-68
references.pmid: 19369657
references.citation: N Engl J Med. 2009 Apr 23;360(17):1701-3
references.pmid: 19369656
references.citation: Drug Metab Rev. 2008;40(2):187-224
references.pmid: 18464043